查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1750771

局部麻醉劑市場規模、佔有率、趨勢分析報告：按藥物、應用、地區、細分市場預測，2025-2030 年

Local Anesthesia Drugs Market Size, Share & Trends Analysis Report By Drug (Bupivacaine, Ropivacaine, Lidocaine, Chloroprocaine, Prilocaine, Benzocaine), By Application (Injectable, Surface Anesthetic), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

局部麻醉劑市場的成長與趨勢：

根據 Grand View Research 的新報告，到 2030 年全球局部麻醉劑市場規模預計將達到 51.3 億美元。

預計從 2025 年到 2030 年，市場複合年成長率為 3.70%。全球範圍內外科手術數量的不斷增加，包括整容手術、牙科整形手術和整形手術，正在推動局部麻醉劑的成長。

需要術後鎮痛的外科手術數量大幅增加，預計這一趨勢將在整個預測期內持續下去。約65.0%的外科手術需要術後鎮痛管理，這可能會推動局部麻醉劑的需求。

Bupivacaine、Articaine和Ropivacaine等新型有效藥物的推出也推動了全球局部麻醉劑市場的成長。新興經濟體醫療支出的增加預計將導致印度、中國和巴西等國的手術數量增加。這將有助於該地區的市場成長。

局部麻醉劑市場報告重點

  • 根據應用，市場細分為注射劑和局部麻醉劑。由於注射劑廣泛應用於各種外科手術，預計在預測期內，注射劑將主導局部麻醉劑市場。藥物輸送系統的進步預計將在預測期內推動局部麻醉劑市場的發展。
  • 由於北美地區進行的外科手術數量眾多，因此佔據局部麻醉劑市場的最大佔有率。
  • 由於都市化的快速推進和醫療保健基礎設施的改善，預計亞太地區的局部麻醉劑行業在預測期內將實現最快的複合年成長率。
  • 按藥物分類，Lidocaine在 2024 年佔據市場主導地位，佔有率為 28.88%。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章局部麻醉劑市場變數、趨勢與範圍

  • 市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 商業環境分析
    • 產業分析—波特五力分析
    • PESTLE分析
    • 管道分析
    • 專利到期分析
    • 定價分析

第4章局部麻醉劑市場：藥品業務分析

  • 2024年及2030年的醫藥市場佔有率
  • 藥品細分儀表板
  • 市場規模、預測與趨勢分析（按藥物，2018-2030 年）
  • Bupivacaine
  • Ropivacaine
  • Lidocaine
  • Chloroprocaine
  • Prilocaine
  • Benzocaine
  • 其他

第5章局部麻醉劑市場：應用業務分析

  • 2024年及2030年的應用市場佔有率
  • 應用程式細分儀表板
  • 市場規模、預測與趨勢分析（按應用，2018-2030 年）
  • 注射
  • 局部麻醉劑

第6章局部麻醉劑市場：區域估計與趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 2018-2030年市場規模與預測趨勢分析：
  • 北美洲
    • 2018-2030年各國情況
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭態勢

  • 參展公司概況
  • 企業市場分析
  • 公司分類
  • 戰略地圖
  • 公司簡介/列表
    • Johnson &Johnson Services, Inc.
    • Pfizer Inc
    • AstraZeneca
    • Novartis AG
    • Teva Pharmaceutical Industries Ltd.
    • GSK plc
    • Sanofi
    • Merck &Co., Inc.
    • Aspen Holdings
    • Viatris Inc.
Product Code: GVR-2-68038-086-6

Local Anesthesia Drugs Market Growth & Trends:

The global local anesthesia drugs market size is anticipated to reach USD 5.13 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 3.70% from 2025 to 2030. The rising number of surgical procedures across the globe, including cosmetic surgeries, dental procedures, and plastic surgeries, is driving the growth of local anesthetics.

There has been a considerable increase in the number of surgical procedures requiring post-operative pain relief and this trend is expected to continue throughout the forecast period. Roughly, 65.0% of total surgical procedures require post-operative pain management. This is likely to boost the demand for local anesthesia drugs.

The introduction of new and effective drugs such as levobupivacaine, articaine, and ropivacaine is also driving the growth of the local anesthesia drugs market across the globe. Rising healthcare expenditure in developing countries is expected to result in an increase in the number of surgeries performed in countries such as India, China, and Brazil. This is likely to contribute to market growth in the region.

Local Anesthesia Drugs Market Report Highlights:

  • By application, the market is bifurcated into injectable and surface anesthetic. The injectable segment is expected to dominate the local anesthesia drugs market during the forecast period owing to extensive usage in different surgical procedures. Advancements in drug delivery systems are expected to drive the market for surface anesthetics over the forecast period.
  • North America held the largest share in the market for local anesthesia drugs owing to a significant number of surgical procedures performed in the region.
  • Asia Pacific local anesthesia drugs industry is anticipated to witness the fastest CAGR over the forecast period due to rapid urbanization and improvements in healthcare infrastructure.
  • By Drug segment, Lidocaine dominated the market with a 28.88% share in 2024, driven by its extensive use in injectable and topical anesthetic formulations.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Drug
    • 1.2.2. Application
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Local Anesthesia Drugs Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Pipeline Analysis
      • 3.3.3.1. Phase 1
      • 3.3.3.2. Phase 2
      • 3.3.3.3. Phase 3
    • 3.3.4. Patent Expiry Analysis
    • 3.3.5. Pricing Analysis

Chapter 4. Local Anesthesia Drugs Market: Drug Business Analysis

  • 4.1. Drug Market Share, 2024 & 2030
  • 4.2. Drug Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Drug, 2018 to 2030 (USD Million)
  • 4.4. Bupivacaine
    • 4.4.1. Bupivacaine Market, 2018 - 2030 (USD Million)
  • 4.5. Ropivacaine
    • 4.5.1. Ropivacaine Market, 2018 - 2030 (USD Million)
  • 4.6. Lidocaine
    • 4.6.1. Lidocaine Market, 2018 - 2030 (USD Million)
  • 4.7. Chloroprocaine
    • 4.7.1. Chloroprocaine Market, 2018 - 2030 (USD Million)
  • 4.8. Prilocaine
    • 4.8.1. Prilocaine Market, 2018 - 2030 (USD Million)
  • 4.9. Benzocaine
    • 4.9.1. Benzocaine Market, 2018 - 2030 (USD Million)
  • 4.10. Others
    • 4.10.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Local Anesthesia Drugs Market: Application Business Analysis

  • 5.1. Application Market Share, 2024 & 2030
  • 5.2. Application Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Injectable
    • 5.4.1. Injectable Market, 2018 - 2030 (USD Million)
  • 5.5. Surface Anesthetic
    • 5.5.1. Surface Anesthetic Market, 2018 - 2030 (USD Million)

Chapter 6. Local Anesthesia Drugs Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America Local Anesthesia Drugs Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Target Disease Prevalence
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. Reimbursement Framework
      • 6.4.2.5. U.S. Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Target Disease Prevalence
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Reimbursement Framework
      • 6.4.3.5. U.S. Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Target Disease Prevalence
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. Reimbursement Framework
      • 6.4.4.5. Mexico Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Target Disease Prevalence
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Reimbursement Framework
      • 6.5.2.5. Uk Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Target Disease Prevalence
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Reimbursement Framework
      • 6.5.3.5. Germany Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Target Disease Prevalence
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Reimbursement Framework
      • 6.5.4.5. France Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Target Disease Prevalence
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. Reimbursement Framework
      • 6.5.5.5. Italy Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Target Disease Prevalence
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. Reimbursement Framework
      • 6.5.6.5. Spain Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Denmark
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Target Disease Prevalence
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. Reimbursement Framework
      • 6.5.7.5. Denmark Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Sweden
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Target Disease Prevalence
      • 6.5.8.3. Regulatory Framework
      • 6.5.8.4. Reimbursement Framework
      • 6.5.8.5. Sweden Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Norway
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Target Disease Prevalence
      • 6.5.9.3. Regulatory Framework
      • 6.5.9.4. Reimbursement Framework
      • 6.5.9.5. Norway Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Target Disease Prevalence
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Reimbursement Framework
      • 6.6.2.5. Japan Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Target Disease Prevalence
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Reimbursement Framework
      • 6.6.3.5. China Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Target Disease Prevalence
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. Reimbursement Framework
      • 6.6.4.5. India Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Australia
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Target Disease Prevalence
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Reimbursement Framework
      • 6.6.5.5. Australia Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. South Korea
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Target Disease Prevalence
      • 6.6.6.3. Regulatory Framework
      • 6.6.6.4. Reimbursement Framework
      • 6.6.6.5. South Korea Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Target Disease Prevalence
      • 6.6.7.3. Regulatory Framework
      • 6.6.7.4. Reimbursement Framework
      • 6.6.7.5. Thailand Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Target Disease Prevalence
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. Reimbursement Framework
      • 6.7.2.5. Japan Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Target Disease Prevalence
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Reimbursement Framework
      • 6.7.3.5. China Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Middle East and Africa
    • 6.8.1. Middle East and Africa Local Anesthesia Drugs Market Estimates and Forecasts, 2017 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Target Disease Prevalence
      • 6.8.2.3. Regulatory Framework
      • 6.8.2.4. Reimbursement Framework
      • 6.8.2.5. South Africa Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Target Disease Prevalence
      • 6.8.3.3. Regulatory Framework
      • 6.8.3.4. Reimbursement Framework
      • 6.8.3.5. Saudi Arabia Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Target Disease Prevalence
      • 6.8.4.3. Regulatory Framework
      • 6.8.4.4. Reimbursement Framework
      • 6.8.4.5. UAE Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Target Disease Prevalence
      • 6.8.5.3. Regulatory Framework
      • 6.8.5.4. Reimbursement Framework
      • 6.8.5.5. Kuwait Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. Johnson & Johnson Services, Inc.
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Pfizer Inc
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. AstraZeneca
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. Novartis AG
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Teva Pharmaceutical Industries Ltd.
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. GSK plc
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. Sanofi
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. Merck & Co., Inc.
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Aspen Holdings
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic Initiatives
    • 7.5.10. Viatris Inc.
      • 7.5.10.1. Overview
      • 7.5.10.2. Financial Performance
      • 7.5.10.3. Product Benchmarking
      • 7.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global local anesthesia drugs market, by region, 2018 - 2030 (USD Million)
  • Table 4 Global local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 5 Global local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 6 North America local anesthesia drugs market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 8 North America local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 9 U.S. local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 10 U.S. local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 12 Canada local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 13 Mexico local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 14 Mexico local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 15 Europe local anesthesia drugs market, by country, 2018 - 2030 (USD Million)
  • Table 16 Europe local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 17 Europe local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 18 UK local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 19 UK local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 20 Germany local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 21 Germany local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 22 France local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 23 France local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 24 Italy local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 25 Italy local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 26 Spain local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 27 Spain local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 28 Norway local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 29 Norway local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 30 Denmark local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 31 Denmark local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 32 Sweden local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 33 Sweden local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific local anesthesia drugs market, by country, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 37 Japan local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 38 Japan local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 39 China local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 40 China local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 41 India local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 42 India local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 43 Australia local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 44 Australia local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 45 South Korea local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 46 South Korea local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 47 Thailand local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 48 Thailand local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 49 Latin America local anesthesia drugs market, by country, 2018 - 2030 (USD Million)
  • Table 50 Latin America local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 51 Latin America local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 52 Brazil local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 53 Brazil local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 54 Argentina local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 55 Argentina local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa local anesthesia drugs market, by country, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 58 Middle East & Africa local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 59 South Africa local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 60 South Africa local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 63 UAE local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 64 UAE local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 65 Kuwait local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 66 Kuwait local anesthesia drugs market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Local anesthesia drugs market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Segment snapshot
  • Fig. 10 Competitive landscape
  • Fig. 11 Local anesthesia drugs market dynamics
  • Fig. 12 Local anesthesia drugs market: Porter's five forces analysis
  • Fig. 13 Local anesthesia drugs market: PESTLE analysis
  • Fig. 14 Drug market, 2018 - 2030 (USD Million)
  • Fig. 15 Bupivacaine market, 2018 - 2030 (USD Million)
  • Fig. 16 Ropivacaine market, 2018 - 2030 (USD Million)
  • Fig. 17 Lidocaine market, 2018 - 2030 (USD Million)
  • Fig. 18 Chloroprocaine market, 2018 - 2030 (USD Million)
  • Fig. 19 Prilocaine market, 2018 - 2030 (USD Million)
  • Fig. 20 Benzocaine market, 2018 - 2030 (USD Million)
  • Fig. 21 Others market, 2018 - 2030 (USD Million)
  • Fig. 22 Application market, 2018 - 2030 (USD Million)
  • Fig. 23 Injectable market, 2018 - 2030 (USD Million)
  • Fig. 24 Surface Anesthetic market, 2018 - 2030 (USD Million)
  • Fig. 25 Local anesthesia drugs market revenue, by region
  • Fig. 26 Regional marketplace: Key takeaways
  • Fig. 27 North America local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 28 U.S. country dynamics
  • Fig. 29 U.S. local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 30 Canada country dynamics
  • Fig. 31 Canada local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 32 Mexico country dynamics
  • Fig. 33 Mexico local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 34 Europe local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 35 UK country dynamics
  • Fig. 36 UK local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 37 Germany country dynamics
  • Fig. 38 Germany local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 39 France country dynamics
  • Fig. 40 France local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 41 Italy country dynamics
  • Fig. 42 Italy local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 43 Spain country dynamics
  • Fig. 44 Spain local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 45 Norway country dynamics
  • Fig. 46 Norway local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 47 Sweden country dynamics
  • Fig. 48 Sweden local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 49 Denmark country dynamics
  • Fig. 50 Denmark local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 51 Asia Pacific local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 52 Japan country dynamics
  • Fig. 53 Japan local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 54 China country dynamics
  • Fig. 55 China local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 56 India country dynamics
  • Fig. 57 India local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 58 Australia country dynamics
  • Fig. 59 Australia local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 60 South Korea country dynamics
  • Fig. 61 South Korea local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 62 Thailand country dynamics
  • Fig. 63 Thailand local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 64 Latin America local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 65 Brazil country dynamics
  • Fig. 66 Brazil local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 67 Argentina country dynamics
  • Fig. 68 Argentina local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 69 MEA local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 70 South Africa country dynamics
  • Fig. 71 South Africa local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 72 Saudi Arabia country dynamics
  • Fig. 73 Saudi Arabia local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 74 UAE country dynamics
  • Fig. 75 UAE local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 76 Kuwait country dynamics
  • Fig. 77 Kuwait local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 78 Company categorization
  • Fig. 79 Company market position analysis, 2024
  • Fig. 80 Strategic framework